ResearcherJohannes Kepler University of LinzActive in the last 2 years

Matthias Biebl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3690-8614; OpenAlex author ID A5026056648. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

The Progress of Pancreatectomy for Pancreatic Cancer Treatment-Lessons Learned and Future Challenges. First author DOI 10.3390/cancers18142297 ↗
Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. Co-author DOI 10.3389/fonc.2022.902177 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

R. Függer · 1 shared paper, 2026 · strength 0.63
- Paper The Progress of Pancreatectomy for Pancreatic Cancer Treatment-Lessons Learned and Future Challenges. DOI 10.3390/cancers18142297 ↗
Helwig Wundsam · 1 shared paper, 2022 · strength 0.15
- Paper Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. DOI 10.3389/fonc.2022.902177 ↗
Holger F. Rumpold · 1 shared paper, 2022 · strength 0.15
- Paper Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. DOI 10.3389/fonc.2022.902177 ↗
Patrick Kirchweger · 1 shared paper, 2022 · strength 0.15
- Paper Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer. DOI 10.3389/fonc.2022.902177 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.